The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Retinal vascular occlusions
Open accessAbstract
Unstructured summary Acute retinal vascular occlusions are common causes of visual impairment. While both retinal artery occlusions (RAOs) and retinal vein occlusions (RVOs) are associated with increased age and cardiovascular risk factors, their pathophysiology, systemic implications, and management differ significantly. Acute management of RAOs involves a multidisciplinary approach including neurologists with stroke expertise, while RVO treatment is provided by ophthalmologists; optimization of systemic risk factors by patients’ primary care providers is an important component of RAO and RVO management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Artificial intelligence and deep learning in ophthalmology
Ting, D. S. W., Pasquale, L. R., Peng, L., Campbell, J. P., Lee, A. Y., Raman, R., Tan, G. S. W., Schmetterer, L., Keane, P. A., & Wong, T. Y. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-313173 · Cited by 1,554
Artificial Intelligence and Deep Learning in Ophthalmology
Wang, Z., Keane, P. A., Chiang, M., Cheung, C. Y., Wong, T. Y., & Ting, D. S. W. (2022) · Artificial Intelligence in Medicine · doi:10.1007/978-3-030-64573-1_200 · Cited by 1,524
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I., Kernan, W. N., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Hellmich, B., Agueda, A., Monti, S., Buttgereit, F., de Boysson, H., Brouwer, E., Cassie, R., Cid, M. C., Dasgupta, B., Dejaco, C., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215672 · Cited by 1,200
Rothwell, P. M., Giles, M. F., Chandratheva, A., Marquardt, L., Geraghty, O., Redgrave, J. N., Lovelock, C. E., Binney, L. E., Bull, L. M., Cuthbertson, F. C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61448-2 · Cited by 1,190
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Self-citation
Cited by
More than meets the eye: The role of microglia in healthy and diseased retina
Murenu, E., Gerhardt, M.-J., Biel, M., & Michalakis, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006897 · Cited by 73
Metadata
- Authors
- Scott, I. U., Campochiaro, P. A., Newman, N. J., & Biousse, V.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 396
- Issue
- 10266
- Pages
- 1927-1940
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W3111867831
- Cited by
- 307
- References
- 100
- FWCI
- 18.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinal vascular occlusions. https://app.cochat.ai/papers/10.1016/s0140-6736(20)31559-2
- The paper
- Scott, I. U., Campochiaro, P. A., Newman, N. J., & Biousse, V. (2020). Retinal vascular occlusions. The Lancet. https://doi.org/10.1016/s0140-6736(20)31559-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.